These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 9720779)
1. Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro. Haskó G; Szabó C; Németh ZH; Lendvai B; Vizi ES Br J Pharmacol; 1998 Jul; 124(6):1099-106. PubMed ID: 9720779 [TBL] [Abstract][Full Text] [Related]
2. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. Haskó G; Szabó C; Németh ZH; Kvetan V; Pastores SM; Vizi ES J Immunol; 1996 Nov; 157(10):4634-40. PubMed ID: 8906843 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700 [TBL] [Abstract][Full Text] [Related]
4. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages. Guruvayoorappan C; Kuttan G Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575 [TBL] [Abstract][Full Text] [Related]
6. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10. Fukuda T; Hisadome M; Komatsu H J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Barsig J; Küsters S; Vogt K; Volk HD; Tiegs G; Wendel A Eur J Immunol; 1995 Oct; 25(10):2888-93. PubMed ID: 7589088 [TBL] [Abstract][Full Text] [Related]
8. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages. Chen BC; Hsieh SL; Lin WW J Leukoc Biol; 2001 Feb; 69(2):280-8. PubMed ID: 11272279 [TBL] [Abstract][Full Text] [Related]
9. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074 [TBL] [Abstract][Full Text] [Related]
10. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Fouqueray B; Boutard V; Philippe C; Kornreich A; Marchant A; Perez J; Goldman M; Baud L Am J Pathol; 1995 Jul; 147(1):176-82. PubMed ID: 7604878 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823 [TBL] [Abstract][Full Text] [Related]
12. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432. Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639 [TBL] [Abstract][Full Text] [Related]
14. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues. Bradshaw M; Rutherford MS; Hoeper BJ; McWhinney CD; Borcherding DR; Schook LB; Edwards CK J Pharmacol Exp Ther; 1995 Jun; 273(3):1506-18. PubMed ID: 7791126 [TBL] [Abstract][Full Text] [Related]
15. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Wu GJ; Chen TL; Ueng YF; Chen RM Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973 [TBL] [Abstract][Full Text] [Related]
16. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats. Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430 [TBL] [Abstract][Full Text] [Related]
17. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages. Avni D; Goldsmith M; Ernst O; Mashiach R; Tuntland T; Meijler MM; Gray NS; Rosen H; Zor T Immunol Lett; 2009 Mar; 123(1):1-8. PubMed ID: 19185589 [TBL] [Abstract][Full Text] [Related]
18. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Schippers EF; van 't Veer C; van Voorden S; Martina CA; Huizinga TW; le Cessie S; van Dissel JT Cytokine; 2005 Mar; 29(5):215-28. PubMed ID: 15760678 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Chen RM; Chen TG; Chen TL; Lin LL; Chang CC; Chang HC; Wu CH Ann N Y Acad Sci; 2005 May; 1042():262-71. PubMed ID: 15965071 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. Trepicchio WL; Bozza M; Pedneault G; Dorner AJ J Immunol; 1996 Oct; 157(8):3627-34. PubMed ID: 8871663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]